IDXX - IDEXX LABORATORIES INC /DE

560.93
-17.420   -3.106%

Share volume: 625,626
Last Updated: 04-23-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$578.35
-17.42
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
56%
Profitability 81%
Dept financing 25%
Liquidity 5%
Performance 52%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-3.80%
1 Month
-1.63%
3 Months
-19.62%
6 Months
-12.47%
1 Year
27.20%
2 Year
13.49%
Key data
Stock price
$560.93
P/E Ratio 
50.99
DAY RANGE
$554.49 - $577.85
EPS 
$13.17
52 WEEK RANGE
$427.70 - $769.98
52 WEEK CHANGE
$28.23
MARKET CAP 
54.022 B
YIELD 
N/A
SHARES OUTSTANDING 
79.624 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-04-2025
BETA 
0.89
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$480,965
AVERAGE 30 VOLUME 
$510,570
Company detail
CEO: Jonathan J. Mazelsky
Region: US
Website: idexx.com
Employees: 10,800
IPO year: 1991
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for companion animal veterinary, livestock and poultry, dairy, and water testing markets. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides veterinary diagnostic products, including instruments, consumables, and rapid assay test kits.

Recent news